ArticlePlant biotechnology journal2025
The CsLOB1-CsERF027 Regulatory Module Positively Enhances Citrus Target Spot Disease Resistance by Regulating CsRAP2.3-CsERF1 Cascade.
Article in Plant biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Citrus target spot disease poses significant threats to the citrus industry. However, the molecular mechanisms underlying citrus resistance to Pseudofabraea citricarpa remain unexplored. In this study, we identified the LBD family gene CsLOB1 and investigated its molecular responses to pathogen infection. Following P. citricarpa inoculation, exogenous methyl jasmonate (MeJA) and ethylene (ET), CsLOB1 expression levels in 'Eureka' citrus were significantly higher than in 'Tarocco' blood orange. OE-CsLOB1 transgenic Citrus sinensis exhibited reduced susceptibility to P. citricarpa concomitant with enhanced expression of systemic acquired resistance marker genes (CsPR1, CsPR2 and CsPR4), maintaining reactive oxygen species (ROS) homeostasis and reductions in H
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.